Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 9:15 PM ET

Biotechnology

Company Overview of Caladrius Biosciences, Inc.

Executive Profile

Arshed A. Quyyumi M.D., FRCP, FACC

Member of Cardiovascular Disease Scientific Advisory Board, Caladrius Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Arshed A. Quyyumi, also known as Ali, M.D., FRCP, FACC, has been a Professor of Medicine in the Division of Cardiology at Emory University School of Medicine since 2001. Dr. Quyyumi serves as Co-Director, Emory Clinical Cardiovascular Research Institute (ECCRI) and Emory Cardiovascular Research. From 1986 to 2001, he served in several capacities at the National Institutes of Health in Bethesda, MD, including: chief resident of cardiology, Senior Investigator, and ...

Corporate Headquarters

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-584-4180
Fax: 646-514-7787

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
University Of London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robin C. Stracey Chief Executive Officer and Director
Cesca Therapeutics Inc.
$283.0K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Ian John Massey D.PhilChief Executive Officer, President, Director and Member of Strategic Transactions Committee
StemCells Inc.
--
Linda Marban Ph.D.Co-Founder, Chief Executive Officer, President and Director
Capricor Therapeutics, Inc.
$232.9K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$246.1K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Caladrius Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.